These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19101403)

  • 1. Sequential or combination chemotherapy for a patient with mCRC?
    Arnold D
    Cancer Treat Rev; 2008; 34 Suppl 2():S12-6. PubMed ID: 19101403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and safety of bevacizumab (BEV) plus chemotherapeutic agents in the treatment of metastatic colorectal cancer, mCRC].
    Guo X; Liu TS; Yu YY; Zhou YH; Chen Y; Zhuang RY; Cui YH
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):604-7. PubMed ID: 24314219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XELOX plus bevacizumab vs. FOLFIRI plus bevacizumab treatment for first-line chemotherapy in metastatic colon cancer: a retrospective study of the Anatolian Society of Medical Oncology.
    Duran AO; Karaca H; Besiroglu M; Bayoglu IV; Menekse S; Yapici HS; Yazilitas D; Bahceci A; Uysal M; Sevinc A; Hacibekiroglu I; Aksoy A; Tanriverdi O; Arpaci E; Inanc M; Dane F; Ozkan M
    Asian Pac J Cancer Prev; 2014; 15(23):10375-9. PubMed ID: 25556478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bevacizumab in first-line therapy of metastatic colorectal cancer: a retrospective comparison of FOLFIRI and XELIRI.
    Ocvirk J; Rebersek M; Boc M
    Anticancer Res; 2011 May; 31(5):1777-82. PubMed ID: 21617239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of unresectable multiple hepatic metastases from ascending colon cancer successfully treated with panitumumab and FOLFIRI(5-FU/LV/irinotecan)therapy].
    Yoshida R; Matsuura T; Hijikawa K; Yanagida H; Kitade H; Takada H; Kwon AH
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1575-7. PubMed ID: 23064076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver resection after FOLFOX with bevacizumab.
    Mickle M; Mulcahy MF
    Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):12-4. PubMed ID: 17491587
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrent disease four years after surgery and adjuvant chemotherapy.
    Pozzo C; Barone C
    Cancer Treat Rev; 2008; 34 Suppl 2():S8-11. PubMed ID: 19101406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and radiological response with FOLFOXIRI and bevacizumab as third-line therapy after mFOLFOX6 and FOLFIRI failure.
    de Melo JV; Vieira de Melo MS; Abad MH
    Anticancer Drugs; 2011 Jun; 22 Suppl 2():S19-20. PubMed ID: 21768793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy of metastatic colorectal cancer.
    Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical efficacy of FOLFIRI and bevacizumab in combination as first-line therapy of metastatic colorectal cancer.
    Grothey E; Chu E
    Clin Colorectal Cancer; 2007 Sep; 6(9):621-4. PubMed ID: 17945033
    [No Abstract]   [Full Text] [Related]  

  • 11. [A case of synchronous multiple liver metastasis of sigmoid colon cancer with a pathological complete response to combination chemotherapy of 5-FU/LV and bevacizumab].
    Uegami S; Imamura Y; Daimaru Y; Nakamitsu A; Kouyama M; Kuwada A; Toge K; Taogoshi H; Yokoyama S; Fukuda Y
    Gan To Kagaku Ryoho; 2011 Feb; 38(2):321-4. PubMed ID: 21368505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of bevacizumab combined with chemotherapy for the treatment of metastatic colorectal cancer in Japan.
    Shiroiwa T; Fukuda T; Tsutani K
    Clin Ther; 2007 Oct; 29(10):2256-67. PubMed ID: 18042483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [mFOLFOX6 and FOLFIRI/bevacizumab treatment in a patient on hemodialysis with metastatic colon cancer].
    Kuwabara H; Baba H; Wakabayashi M; Nakamura H; Sanada T; Baba H; Nakajima K; Goseki N
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2250-2. PubMed ID: 22202345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of a recurrent hepatic metastasis occurred after curative resection of ascending colon cancer and a hepatic metastasis responding completely to capecitabine plus bevacizumab].
    Murayama M; Kohno T; Miyazawa M; Shimazaki A; Miyaki A; Usuda A; Asaka S; Yamaguchi K; Yokomizo H; Shiozawa S; Yoshimatsu K; Shimakawa T; Katsube T; Naritaka Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2014-6. PubMed ID: 24393997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab in the treatment of colorectal cancer.
    Marshall JL
    Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):8-9. PubMed ID: 17491585
    [No Abstract]   [Full Text] [Related]  

  • 17. Bevacizumab-associated reversible hypotension.
    Iqbal K; Chu Q; Mei Q; Chen Y
    Clin Oncol (R Coll Radiol); 2007 Dec; 19(10):800-1. PubMed ID: 17825542
    [No Abstract]   [Full Text] [Related]  

  • 18. Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen.
    Van Cutsem E; Tabernero J; Lakomy R; Prenen H; Prausová J; Macarulla T; Ruff P; van Hazel GA; Moiseyenko V; Ferry D; McKendrick J; Polikoff J; Tellier A; Castan R; Allegra C
    J Clin Oncol; 2012 Oct; 30(28):3499-506. PubMed ID: 22949147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemotherapy of colonic cancer].
    Block S
    Soins; 2010 Mar; (743):46. PubMed ID: 20423037
    [No Abstract]   [Full Text] [Related]  

  • 20. Dural sinus vein thrombosis in a patient with colon cancer treated with FOLFIRI/bevacizumab.
    Ozen A; Cicin I; Sezer A; Uzunoglu S; Saynak M; Genchellac H; Karagol H
    J Cancer Res Ther; 2009; 5(2):130-2. PubMed ID: 19542672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.